publicationMetadata:
  pmid: "37328102"
  title: "Inhibition of Erb-B2 Receptor Tyrosine Kinase 3 and Associated Regulatory Pathways Potently Impairs Malignant Peripheral Nerve Sheath Tumor Proliferation and Survival"
  queryType: "unknown"  # Not specified in input data
  publicationType: "Lab Research"
  publicationTypeConfidence: 0.95
  hasMethodsSection: No
  likelyContainsTools: Yes
  expectedToolTypes: |
    Based on the abstract content, this is clearly a laboratory research study that should contain:
    - Cell lines (MPNST cell lines and Schwann cells mentioned)
    - Genetic reagents (shRNA screens mentioned)
    - Computational tools (kinomic and microarray analyses mentioned)
    - Chemical compounds/inhibitors (multiple drug inhibitors mentioned: canertinib, sapitinib, saracatinib, AZD1208, trifluoperazine)
    
    The study involves molecular biology techniques, cell culture, drug screening, and genomic analyses,
    all of which typically require specific research tools and reagents.
  overallAssessment: |
    This publication describes laboratory research involving MPNST cell lines, drug screening, and molecular
    analyses. The abstract mentions specific techniques (shRNA screens, kinomic analysis, microarray analysis)
    and multiple drug compounds, indicating extensive use of research tools. The absence of mined tools suggests
    significant under-mining, likely because only the abstract was available for analysis rather than full text.

toolValidations: []  # No tools were mined to validate

potentiallyMissedTools:
  - toolName: "canertinib"
    toolType: "genetic_reagent"
    foundIn: "abstract"
    contextSnippet: "...inhibition of upstream (canertinib, sapitinib, saracatinib, and calmodulin) and parallel (AZD1208) signaling pathways..."
    whyMissed: "Drug inhibitor mentioned multiple times in abstract but not captured by mining patterns"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "sapitinib"
    toolType: "genetic_reagent"
    foundIn: "abstract"
    contextSnippet: "...inhibition of upstream (canertinib, sapitinib, saracatinib, and calmodulin) and parallel (AZD1208) signaling pathways..."
    whyMissed: "Drug inhibitor mentioned multiple times in abstract but not captured by mining patterns"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "saracatinib"
    toolType: "genetic_reagent"
    foundIn: "abstract"
    contextSnippet: "...inhibition of upstream (canertinib, sapitinib, saracatinib, and calmodulin) and parallel (AZD1208) signaling pathways..."
    whyMissed: "Src family kinase inhibitor mentioned multiple times but not captured by mining patterns"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "AZD1208"
    toolType: "genetic_reagent"
    foundIn: "abstract"
    contextSnippet: "...inhibition of upstream (canertinib, sapitinib, saracatinib, and calmodulin) and parallel (AZD1208) signaling pathways..."
    whyMissed: "PIM kinase inhibitor mentioned multiple times but not captured by mining patterns"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "trifluoperazine"
    toolType: "genetic_reagent"
    foundIn: "abstract"
    contextSnippet: "...calmodulin [trifluoperazine (TFP)], or proviral integration site of Moloney murine leukemia kinase (AZD1208) inhibition..."
    whyMissed: "Calmodulin inhibitor with abbreviation TFP mentioned but not captured"
    confidence: 0.85
    shouldBeAdded: Yes

  - toolName: "MPNST cell lines"
    toolType: "cell_line"
    foundIn: "abstract"
    contextSnippet: "...erbB3 is commonly expressed in MPNSTs and MPNST cell lines and that erbB3 knockdown inhibits MPNST proliferation..."
    whyMissed: "Cell lines mentioned but generic term not captured by specific cell line naming patterns"
    confidence: 0.8
    shouldBeAdded: Maybe

  - toolName: "Schwann cells"
    toolType: "cell_line"
    foundIn: "abstract"
    contextSnippet: "...Kinomic and microarray analyses of Schwann and MPNST cells implicate Src- and erbB3-mediated..."
    whyMissed: "Primary cell type mentioned in experimental context but not captured"
    confidence: 0.75
    shouldBeAdded: Maybe

  - toolName: "shRNA"
    toolType: "genetic_reagent"
    foundIn: "abstract"
    contextSnippet: "...previous studies used genome-scale shRNA screens that implicated the neuregulin-1 receptor..."
    whyMissed: "Genetic screening tool mentioned but not captured by current patterns"
    confidence: 0.85
    shouldBeAdded: Yes

suggestedPatterns:
  - patternType: "term"
    pattern: "\\b[A-Z]{2,}[0-9]{3,4}\\b"
    toolType: "genetic_reagent"
    examples: ["AZD1208", "canertinib", "sapitinib"]
    reasoning: "Many drug inhibitors follow alphanumeric naming conventions that could be captured with this pattern"

  - patternType: "context_phrase"
    pattern: "inhibitor|inhibition|antagonist|agonist"
    toolType: "genetic_reagent"
    examples: ["canertinib inhibitor", "saracatinib inhibition", "TFP inhibition"]
    reasoning: "Drug compounds are often mentioned with inhibitor/inhibition context that could help identify chemical tools"

  - patternType: "term"
    pattern: "\\bshRNA\\b|\\bsiRNA\\b|\\bmiRNA\\b"
    toolType: "genetic_reagent"
    examples: ["shRNA screens", "shRNA knockdown"]
    reasoning: "RNA interference tools are commonly used genetic reagents that should be captured"

  - patternType: "context_phrase"
    pattern: "cell lines?|cells? lines?|cultured cells?"
    toolType: "cell_line"
    examples: ["MPNST cell lines", "Schwann cells"]
    reasoning: "Generic cell line mentions could be captured when followed by specific cell type names"

  - patternType: "naming_convention"
    pattern: "\\b[A-Za-z]+tinib\\b"
    toolType: "genetic_reagent"
    examples: ["canertinib", "sapitinib"]
    reasoning: "Many kinase inhibitors end in '-tinib' suffix and represent important chemical tools"

observations: []  # No validated tools to extract observations from

summary:
  totalToolsMined: 0
  toolsAccepted: 0
  toolsRejected: 0
  toolsUncertain: 0
  potentiallyMissedCount: 8
  newPatternsCount: 5
  observationsExtracted: 0
  observationsByType: {}
  majorIssuesFound: |
    - No tools were mined despite clear evidence of extensive tool usage in the abstract
    - Only abstract text was available for analysis, missing Methods section that would contain detailed tool information
    - Multiple drug inhibitors (canertinib, sapitinib, saracatinib, AZD1208, trifluoperazine) mentioned but not captured
    - Cell lines (MPNST cell lines, Schwann cells) mentioned but not identified
    - Genetic reagents (shRNA) mentioned but not captured
    - This represents significant under-mining of a tool-rich laboratory research publication
  recommendations: |
    This publication should be re-mined with improved patterns to capture:
    1. Drug inhibitors and chemical compounds (canertinib, sapitinib, saracatinib, AZD1208, trifluoperazine)
    2. Genetic reagents (shRNA screens)
    3. Cell lines (MPNST cell lines, Schwann cells)
    
    The mining patterns need enhancement to capture:
    - Alphanumeric drug names (AZD1208 pattern)
    - Kinase inhibitors ending in '-tinib'
    - RNA interference tools (shRNA, siRNA)
    - Generic cell line mentions with specific cell types
    
    Full text access would significantly improve tool identification as Methods sections typically
    contain detailed protocols and reagent information. The abstract-only analysis likely missed
    many additional tools that would be present in the complete manuscript.
    
    No observations could be extracted since no tools were validated and Results/Discussion sections
    were not available.
